Close Menu

NEW YORK (GenomeWeb) – The New York Genome Center said today that it has received $6 million in funding for its Center for Genomics of Neurodegenerative Disease (CGND) from two foundations.

The ALS Association is committing $3.5 million to the CGND, including a $1 million commitment from its Greater New York chapter. In addition, the Tow Foundation is contributing $2.5 million.

Previously, following the 2014 Ice Bucket Challenge, the ALS Association gave $2.5 million to the CGND to match a $2.5 million gift from the Tow Foundation.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

At the Lancet, more than two dozen public health researchers condemn the conspiracy theories that have emerged surrounding the source of the COVID-19 outbreak.

The Washington Post reports that Philip Leder, who helped uncover how DNA codes for proteins and studied the role of genes in cancer, has died.

Researchers from Trinity College Dublin and the University of Pittsburgh look into how often de novo genes arise and how important they may be.

In Nucleic Acids Research this week: pipeline for genotyping Alu retrotransposon mobile element insertions, previously undocumented non-coding RNAs, and more.